Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Hepatic Insufficiency » Liver Failure
Description
Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed) MeSH
Hierarchy View
Subtype Terms (3)
End Stage Liver Disease
38 drugs (25 approved, 13 experimental)
Hepatic Encephalopathy
65 drugs (33 approved, 32 experimental)
Liver Failure, Acute
25 drugs (15 approved, 10 experimental)
Phase 3 Indicated Drugs (9)
Phase 2 Indicated Drugs (11)
Other Experimental Indicated Drugs (8)
Organization Involved with Phase 4 Indications (17)
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization Involved with Phase 3 Indications (25)
Asian Institute of Gastroenterology
Assistance Publique - Hôpitaux de Paris
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
Organization Involved with Phase 2 Indications (38)
All India Institute of Medical Sciences
Betta Pharmaceuticals Co.,Ltd.
CTI Clinical Trial and Consulting Services
French National Agency for Research on AIDS and Viral Hepatitis
Istituto Clinico Humanitas - Rozzano (MI), Italy
National Institute of Allergy and Infectious Diseases (NIAID)
Organization Involved with Phase 1 Indications (48)
Organization Involved with Other Experimental Indications (24)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
